Paradigm shift in clinical trial regulations in India
India has the potential to contribute meaningfully to global clinical drug development. A critical enabler to achieve this potential is a balanced, predictable, and scientifically robust regulation involving clinical studies. In the past few years, the country's regulatory milieu has witnessed...
Saved in:
| Main Authors: | Sandeep Lahiry, Rajasree Sinha, Shouvik Choudhury, Ayan Mukherjee, Suparna Chatterjee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2018-01-01
|
| Series: | Indian Journal of Rheumatology |
| Subjects: | |
| Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2018;volume=13;issue=1;spage=51;epage=55;aulast=Lahiry |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The landscape of Phase IV Clinical Trials in India – A comprehensive analysis of the Clinical Trial Registry-India
by: Bikash Ranjan Meher, et al.
Published: (2025-07-01) -
Requirements and special considerations for drug trials with children across six jurisdictions: 1. Clinical trial application review in the regulatory approval process
by: Breanne Stewart, et al.
Published: (2025-04-01) -
Introduction of clinical guidelines for the diagnosis and treatment of osteoarthrosis: results of a cluster randomized trial
by: Dmitri Mikhailovich Maksimov, et al.
Published: (2012-08-01) -
Indian national guidelines for stem cell research (2017): Summary
by: Sandeep Lahiry, et al.
Published: (2019-01-01) -
PARADIGM SHIFT OF WOMEN'S PROPERTY RIGHTS IN INDIA: EVOLUTION, CHALLENGES, AND RECOMMENDATIONS
by: Priya Sepaha, et al.
Published: (2024-12-01)